Viemed Healthcare, Inc. $VMD Shares Purchased by Gabelli Funds LLC

Key Points

• Gabelli Funds LLC increased its holdings in Viemed Healthcare by 64.9% in the first quarter, acquiring an additional 45,837 shares for a total value of $848,000.
• Other major investors like Divisadero Street Capital and Northern Trust have also significantly increased their stakes, indicating strong institutional interest in Viemed Healthcare.
• Viemed Healthcare reported a net margin of 5.80% for the last quarter, with earnings matching analyst expectations at $0.08 per share.

Gabelli Funds LLC grew its position in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 64.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 116,510 shares of the company's stock after purchasing an additional 45,837 shares during the quarter. Gabelli Funds LLC owned approximately 0.29% of Viemed Healthcare worth $848,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Millennium Management LLC purchased a new stake in Viemed Healthcare during the fourth quarter worth about $573,000. Ameriprise Financial Inc. purchased a new position in shares of Viemed Healthcare during the fourth quarter worth approximately $340,000. Nuveen Asset Management LLC increased its stake in shares of Viemed Healthcare by 22.1% in the fourth quarter. Nuveen Asset Management LLC now owns 162,272 shares of the company's stock worth $1,301,000 after buying an additional 29,320 shares during the period. Northern Trust Corp increased its position in Viemed Healthcare by 1.8% during the 4th quarter. Northern Trust Corp now owns 286,818 shares of the company's stock valued at $2,300,000 after purchasing an additional 5,090 shares during the period. Finally, Deutsche Bank AG boosted its holdings in shares of Viemed Healthcare by 2,891.5% during the 4th quarter. Deutsche Bank AG now owns 23,214 shares of the company's stock valued at $186,000 after buying an additional 22,438 shares in the last quarter. 74.24% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Viemed Healthcare news, President Michael Moore sold 50,090 shares of the company's stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $7.33, for a total value of $367,159.70. Following the completion of the transaction, the president directly owned 126,343 shares in the company, valued at $926,094.19. This represents a 28.39% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Nitin Kaushal sold 34,100 shares of the stock in a transaction that occurred on Friday, June 27th. The shares were sold at an average price of $7.01, for a total value of $239,041.00. Following the transaction, the director owned 126,843 shares of the company's stock, valued at $889,169.43. This represents a 21.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 97,922 shares of company stock worth $703,886 in the last three months. 20.00% of the stock is owned by company insiders.

Viemed Healthcare Stock Down 0.1%

Viemed Healthcare stock traded down $0.01 during mid-day trading on Wednesday, reaching $6.80. The stock had a trading volume of 243,684 shares, compared to its average volume of 179,476. The company has a market capitalization of $263.77 million, a price-to-earnings ratio of 20.00 and a beta of 1.38. The company has a 50-day moving average price of $6.81 and a two-hundred day moving average price of $6.96. Viemed Healthcare, Inc. has a one year low of $5.93 and a one year high of $9.81. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.48 and a quick ratio of 1.37.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.08. Viemed Healthcare had a net margin of 5.80% and a return on equity of 10.38%. The business had revenue of $63.06 million for the quarter, compared to analysts' expectations of $63.50 million.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.